LGALS9 and COVID-19: (21) reported that patients with both severe and non-severe forms of COVID-19 had significantly higher levels of Gal-9 than controls (2044 [1385-3303] pg/ml, and 2811 [1866-4371] pg/ml vs. 739 [495-960] pg/ml, respectively).